Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biolife Solutions (BLFS)

Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,243,663
  • Shares Outstanding, K 48,148
  • Annual Sales, $ 82,250 K
  • Annual Income, $ -20,180 K
  • EBIT $ -9 M
  • EBITDA $ 0 M
  • 60-Month Beta 1.93
  • Price/Sales 14.93
  • Price/Cash Flow 208.22
  • Price/Book 3.47

Options Overview Details

View History
  • Implied Volatility 91.32% (-4.73%)
  • Historical Volatility 41.23%
  • IV Percentile 56%
  • IV Rank 47.73%
  • IV High 134.47% on 11/17/25
  • IV Low 51.91% on 08/18/25
  • Expected Move (DTE 14) 0.85 (3.34%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 2
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 179
  • Open Int (30-Day) 181
  • Expected Range 24.61 to 26.31

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.03
  • Number of Estimates 2
  • High Estimate 0.00
  • Low Estimate -0.05
  • Prior Year -0.01
  • Growth Rate Est. (year over year) -200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.57 +8.02%
on 11/18/25
28.24 -9.84%
on 11/06/25
-2.11 (-7.65%)
since 11/05/25
3-Month
23.47 +8.48%
on 09/25/25
29.62 -14.04%
on 10/24/25
-1.00 (-3.78%)
since 09/05/25
52-Week
19.10 +33.30%
on 04/09/25
29.62 -14.04%
on 10/24/25
+0.28 (+1.11%)
since 12/05/24

Most Recent Stories

More News
BioLife Solutions Unveils the Aby J. Mathew Center for Biopreservation Excellence

New conference and laboratory facility to showcase the company's product portfolio and serve as a research and training hub to advance biopreservation and cell processing innovation

BLFS : 25.46 (-1.43%)
BioLife Solutions to Participate in Upcoming Investor Conferences in November and December 2025

BOTHELL, Wash. , Nov. 17, 2025 /PRNewswire/ -- BioLife Solutions , Inc.  (NASDAQ: BLFS ), a leading developer and supplier of bioproduction products and services for the...

BLFS : 25.46 (-1.43%)
BioLife Solutions Reports Third Quarter 2025 Financial Results

Cell Processing revenue of $25.4 million, up 33% over Q3 2024

BLFS : 25.46 (-1.43%)
BioLife Solutions to Report Third Quarter 2025 Financial Results and Business Update on November 6, 2025

BOTHELL, Wash. , Oct. 23, 2025 /PRNewswire/ --  BioLife Solutions, Inc . (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy...

BLFS : 25.46 (-1.43%)
BioLife Solutions (BLFS) Gets a Buy from Northland Securities

Northland Securities analyst Carl Byrnes maintained a Buy rating on BioLife Solutions today and set a price target of $31.00. The company’s shares closed yesterday at $26.30.Elevate Your Investing Strategy:...

BLFS : 25.46 (-1.43%)
BioLife Solutions (BLFS) Receives a Buy from Jefferies

Jefferies analyst reiterated a Buy rating on BioLife Solutions today and set a price target of $30.00. The company’s shares closed yesterday at $26.30.Elevate Your Investing Strategy: Take advantage...

BLFS : 25.46 (-1.43%)
Analysts Offer Insights on Healthcare Companies: ClearPoint Neuro (CLPT), BioLife Solutions (BLFS) and Viking Therapeutics (VKTX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ClearPoint Neuro (CLPT – Research Report), BioLife Solutions (BLFS – Research Report) and Viking Therapeutics...

VKTX : 38.55 (-0.05%)
CLPT : 13.54 (-3.70%)
BLFS : 25.46 (-1.43%)
BioLife Solutions Announces the Sale of its evo Cold Chain Logistics Subsidiary

BOTHELL, Wash. , Oct. 7, 2025 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools for the...

BLFS : 25.46 (-1.43%)
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS), Pacific Biosciences (PACB) and Humana (HUM)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on BioLife Solutions (BLFS – Research Report), Pacific Biosciences (PACB – Research Report) and Humana (HUM – Research...

HUM : 257.85 (+1.91%)
PACB : 2.39 (-5.16%)
BLFS : 25.46 (-1.43%)
Analysts’ Top Healthcare Picks: BioLife Solutions (BLFS), Dexcom (DXCM)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioLife Solutions (BLFS – Research Report) and Dexcom (DXCM – Research Report) with bullish sentiments.Elevate...

BLFS : 25.46 (-1.43%)
DXCM : 65.49 (+0.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of...

See More

Key Turning Points

3rd Resistance Point 26.81
2nd Resistance Point 26.39
1st Resistance Point 25.92
Last Price 25.46
1st Support Level 25.03
2nd Support Level 24.61
3rd Support Level 24.14

See More

52-Week High 29.62
Fibonacci 61.8% 25.60
Last Price 25.46
Fibonacci 50% 24.36
Fibonacci 38.2% 23.12
52-Week Low 19.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar